8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0000891092-07-000732
Material agreement · Executive or director change · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading e26480_8k.txt…